Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.

@article{Prasad2001TwocolorCD,
  title={Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.},
  author={Ayya Rajendra Prasad and George W. Divine and Richard J. Zarbo},
  journal={Archives of pathology & laboratory medicine},
  year={2001},
  volume={125 3},
  pages={
          364-74
        }
}
CONTEXT DNA flow cytometry of breast cancer is a proposed tumor marker of prognostic significance that is of controversial clinical utility because of lack of standardization and confirmatory studies. OBJECTIVE To evaluate the prognostic significance of the more informative technique of multiparametric 2-color DNA flow cytometry as recommended by the 1992 DNA Cytometry Consensus Conference. DESIGN Three hundred thirty-two breast carcinomas with 7 to 12 years of follow-up were prospectively… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases

VIEW 7 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.